Medication review with collegial mentoring
Medication review with collegial mentoring has been studied in 1 paper since 2020: 1 trial in people. The newest paper, Jul 11, 2020: “Less Is More: The Impact of Deprescribing Psychotropic Drugs on Behavioral and Psychological Symptoms and Daily Functioning in Nursing Home Patients. Results From the Cluster-Randomized Controlled COSMOS Trial”.
1 paper studies it3 findingsUpdated
See all 1 papers on medication review with collegial mentoring
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Compared to control, the mean change in prescribed psychotropic drugs was reduced both in total and regular number”
None of its findings points the other way.
- 1 lab in 1 country
- Funder: Norges Forskningsråd
- Human trial1
Studies in people
1 study gave medication review with collegial mentoring to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
no change: Has no effect on behavioral and psychological symptoms of dementia up: Improves activities of daily living | Randomized trial4 months | 428 peoplenursing home patientsOlder adults; Patient cohorts | The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, Jul 11, 2020 |
What did studies of medication review with collegial mentoring find?
3Studies of medication review with collegial mentoring measured 3 outcomes: activities of daily living, behavioral and psychological symptoms of dementia and psychotropic drugs.
Activities of daily living
upin humans1
1 study
Activities of daily living
upin humans1
Medication review with collegial mentoring improves activities of daily living in humans.
“Mean change in PSMS showed improvement in the intervention group, and deterioration in the control group”
Human trial4 monthsn = 428
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
Behavioral and psychological symptoms of dementia
no changein humans1
1 study
Behavioral and psychological symptoms of dementia
no changein humans1
Medication review with collegial mentoring showed no clear effect on behavioral and psychological symptoms of dementia in humans.
“mean changes in NPI-NH and CSDD scores did not differ between the groups”
Human trial4 monthsn = 428
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
Psychotropic drugs
downin humans1
1 study
Psychotropic drugs
downin humans1
Medication review with collegial mentoring decreases psychotropic drugs in humans.
“Compared to control, the mean change in prescribed psychotropic drugs was reduced both in total and regular number”
Human trial4 monthsn = 428
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry